OEM/ODM Supplier Orlistat - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore
OEM/ODM Supplier Orlistat - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 100kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information: Not dangerous goods
Introduction
Tofacitinib, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Tofacitinib citrate is used to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate.
Tofacitinib citrate is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs.
Specification (in house)
Item |
Specification |
Appearance |
White or off-white crystalline powder |
Identification |
IR, HPLC |
Water |
≤1.5% |
Related Substances |
TOFA 06 ≤0.15% |
Tofacitinib trans isomer ≤0.15% |
|
Tofacitinib dehydrogenated ≤0.15% |
|
Each unknown impurity ≤0.10% |
|
Total Impurities: ≤1.0% |
|
Residual Solvents |
Ethanol ≤5000ppm |
Benzene ≤2ppm |
|
Toluene ≤890ppm |
|
Chlroroethane ≤1000ppm |
|
N,N-Dimethylformamide ≤800ppm |
|
Palladium ≤10ppm |
|
Dichloromethane ≤600ppm |
|
Sulphated ash |
≤0.1% |
Heavy Metal |
≤10ppm |
Chrial HPLC |
3S, 4S tofacitinib ≤0.15% |
Assay (on anhydrous basis) 98.0-102.0% |
Product detail pictures:
Related Product Guide:
We intention to see quality disfigurement within the creation and supply the ideal support to domestic and overseas buyers wholeheartedly for OEM/ODM Supplier Orlistat - Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer – Neore , The product will supply to all over the world, such as: Suriname, Bhutan, Portland, we are sincerely hope to establish one good long term business relationship with your esteemed company thought this opportunity, based on equal, mutual beneficial and win win business from now till the future.
By Steven from Mexico - 2017.09.26 12:12
This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
By Grace from Chicago - 2018.11.22 12:28